Background: Previous trials have shown that lipid-lowering therapy can improve clinical outcomes and achieve regression of coronary plaques. The TRUTH study, a prospective, open-label, randomized multicenter trial, was designed to evaluate the effect of statins on coronary plaque composition in patients with anigina pectoris by using intravascular ultrasound with Virtual Histology(VH-IVUS) in Japan. The aim of this subanalysis was to examine the effects of statins on coronary plaques in patients with unstable angina.
